Keith Flaherty, MD is the lead investigator for the NCI-MATCH precision medicine cancer trial
Credit
Massachusetts General Hospital
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.